Immunosuppressive therapy for chronic liver disease.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000917:Antibody Formation; D001323:Autoantibodies / Q000302:isolation & purification; D001327:Autoimmune Diseases / Q000628:therapy; D001379:Azathioprine / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000494:pharmacology; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D008107:Liver Diseases / Q000628:therapy*; D011239:Prednisolone / Q000378:metabolism / Q000494:pharmacology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine; D011241:Prednisone